Home/ Supplements/ Niacin/ 5% Pre Fruit Punch

5% Pre Fruit Punch

product on market Powder Rich Piana 5% Nutrition Safety: 97/100
97/100

This product looks safe

  • Niacin: 39mg is 1.1× the Tolerable Upper Intake Level (35mg)
  • 55% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

L-Citrulline is supported by strong evidence for increasing blood flow and exercise performance. B vitamins, including Niacin and B12, play moderate roles in energy metabolism. The overall profile focuses on cardiovascular support and metabolic function.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 39mg is 1.1× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for 5% Pre Fruit Punch
Open Full PDF View on NIH DSLD →
Details

Label Data

9.43 Gram(s)
Serving Size
20
Servings
Other Combinations
Product Type
55%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Total Carbohydrates
1 Gram(s) (1% DV)
39 mg NE (244% DV)
Exceeds UL by 1.1× (UL: 35 mg) 196 studies (A:5, B:63)
6.5 mcg (271% DV)
2.7× RDA — within safe limits 139 studies (A:1, B:44)
4000 mg
Market median: 2000.0mg (275 products)
GlycerSize
1000 mg
1000 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
500 mg
Market median: 500.0mg (223 products) 24 studies (A:0, B:1)
Market median: 180.0mg (239 products) 49 studies (A:1, B:19)
Within RDA (0.3× RDA) 38 studies (A:1, B:7)
Market median: 0.15mg (41 products)
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Formulation Notes

300 mg caffeine per serving 4 g citrulline per serving Fruit punch natural & artificial flavors

Endurance Pump Energy

Metadata

Product Details

DSLD Entry Date2025-08-22
Product TypeOther Combinations
FormPowder
DSLD ID333950
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.